In order to test a near-infrared fluorescent probe in which intramolecular luminescence is suppressed, cells grown by culture can be conventionally used. The probe molecules released in the cell culture medium should not be detected by fluorescence microscopy. Uptake by the cells activates the probe and produces a fluorescent signal from the cells containing the probe. Therefore, the cultured cells can be examined by microscopy to reveal that the activation is due to intracellular uptake of the probe to be tested. Microscopic examination of cultured cells is also a convenient means of determining whether activation occurs in one or more intracellular compartments.
Other strong bands at 1327 and 1670 cm−1 are related to ν(COO-) symmetric and antisymmetric stretching vibrations of the carboxylate anion [36], At 1577 cm−1, there is a sharp band for N–H scissoring of the piperazinium ion, which is seen for piperazine at 1550 cm−1. Sharp and relatively strong bands near 1147 cm−1 are attributed to C–N stretching vibrations. These bands are also present in the spectrum of piperazine. In the region of 1541–1496 cm−1, sharp and relatively strong peaks are attributed to aromatic C–C of the (pdcH)− ring.
X‑ray Crystallographic Structure Determination of 1 Crystal and structure refinement data of compound 1 are given in Table 1. The numbering scheme and the molecular structure are presented in Fig. 1. The molecular structure of 1 shows that two protons are transferred from two pdcH2 to the N atoms of the piperazine. Thus, the cation to anion ratio is 1:2. The piperazinium ring is not planar, having a total puckering amplitude QT of 0.575(2) Å, and a chair conformation [φ = 0.0000 and θ = 0.80(1)°] [37]. The pyrazole ring is planar (the C3–N2–N3–C5, N3–N2–C3–C4, N2–C3–C4–C5, N2–N3–C5–C4 and C3–C4–C5–N3 torsion angles are equal to −0.86(13), 0.95(14), −0.62(13), 0.43(14) and 0.12(14), respectively). In each anion equivalence of the C–N bond lengths (Table 2) suggests some degree of delocalization of π-electron density in these fragments.
The compound 1 has similar structure differing in the number of water molecules [38]. Reported structure (1′) has 4 molecules of water as a monoclinic crystal with space group P21/c and has two molecules per unit cell. Although their syntheses were not the same (the compounds 1′ was obtained from a solution of 3,5-pyrazoledicarboxylic acid, Cd(NO3)2·4H2O and piperazine), but both crystal structure were stabilized by strong intermolecular O–H⋯O and weak C–H⋯O hydrogen bonds, linking the ions to form a three dimensional network [38].
In the structure of 1, two water molecules are interacted by 2 sets of intermolecular O–H⋯O type hydrogen bonding interactions between the water molecules and the oxygen atoms of carboxylate groups, with O···O distances in the range of 2.8894(19)–2.915(2) Å, while in the structure of 1′, four water molecules are interacted by 5 sets of intermolecular O–H⋯O type hydrogen bonding interactions, with O···O distances in the range of 2.746(3)–2.858(3) Å.
Then the interactions between the water molecules become stronger with an increasing number of water. The non-covalent interactions play an important role in self-association of the crystal system. The intermolecular N–H⋯O, N–H⋯N, O–H⋯O and C–H⋯O hydrogen bonds (Table 3) between (pipzH2) 2+ and (pdcH)− are responsible for extending the structure 1, into three dimensions resulting in a supramolecular network. The main intermolecular H-bonding involves a proton on O3 and a carboxyl oxygen [O3–H3O⋯O2#2, 2.435(2) Å, #2=x, y, z+1], while one other strong hydrogen bond involves a proton on N1 and another carboxyl oxygen [N1–H2N⋯O1#2, 2.7650(19) Å] (Table 3).
It is of interest to note that the crystal-packing diagram indicates a layered structure. The space between two layers of (pdcH)− fragments is filled with a layer of (pipzH2) 2+cations and water molecules.
In addition, interactions consisting of ion-pairing and π–π stacking [with centroid–centroid distances=3.552(2) for cg1⋯cg1 (−x, 1−y, 1−z) and 3.354(2) Å for cg1⋯cg1 (1−x, 1−y, 1−z)]; [cg1 is the centroid for the ring N3/N2/C3-C5] between two cations are also present.
In addition, the aromatic C–H stretching vibrations of the pdc2− ligand and pipzH22+ cation should occur in the range 3200–2450 cm− 1[42, 43]. The NH2 + stretching vibrations, which are strongly broadened, are also seen in this range. At 1574 cm−1 there is a sharp band for scissoring N–H of piperazinium ion, which is seen for piperazine in 1550 cm−1. Sharp and relatively strong bands near 1036 cm−1 are attributed to C–N stretching vibration. In the region near 1466 cm−1 sharp and relatively strong bands are attributed to the pdc2− ring vibrations.
[2,2':6',2''-Terpyridin]-4'-ol
Catalog No.:AG0003I7 MDL No.:MFCD06796976
MF:C15H11N3O MW:249.2673
|
Phenol, 3-[2,2':6',2''-terpyridin]-4'-yl-
Catalog No.:AG0003I6 MDL No.:
MF:C21H15N3O MW:325.3633
|
Ethanamine, 2-([2,2':6',2''-terpyridin]-4'-yloxy)-
Catalog No.:AG0003I5 MDL No.:
MF:C17H16N4O MW:292.3351
|
Benzoic acid, 3,5-dichloro-4-hydroxy-, propyl ester
Catalog No.:AG0003I4 MDL No.:MFCD00017629
MF:C10H10Cl2O3 MW:249.0906
|
5-Heptenoic acid, 7-oxo-, methyl ester
Catalog No.:AG0003I3 MDL No.:
MF:C8H12O3 MW:156.1791
|
3-Thiazolidineacetic acid, 4-oxo-5-(phenylmethylene)-2-thioxo-, compd. with 2-aminoethanol (1:1)
Catalog No.:AG0003I2 MDL No.:
MF:C14H16N2O4S2 MW:340.4178
|
1-Phthalazinol, 1,2-dihydro-2-phenyl-
Catalog No.:AG0003I1 MDL No.:
MF:C14H12N2O MW:224.2579
|
4-Pyridinamine, N,N-diethyl-, 1-oxide
Catalog No.:AG0003HZ MDL No.:
MF:C9H14N2O MW:166.2203
|
1,4-Butanediamine, N1-[3-(9-acridinylamino)propyl]-N4-(3-aminopropyl)-
Catalog No.:AG0003HY MDL No.:
MF:C23H33N5 MW:379.5416
|
1,6,19,24-Tetraoxacyclohexatriaconta-3,21-diene-2,5,20,23-tetrone
Catalog No.:AG0003HX MDL No.:
MF:C32H52O8 MW:564.7505
|
3-Hexanone, 6-nitro-
Catalog No.:AG0003HW MDL No.:
MF:C6H11NO3 MW:145.1564
|
D-Gluconic acid, strontium salt (2:1)
Catalog No.:AG0003I9 MDL No.:
MF:C12H22O14Sr MW:477.9147
|
Histidine, N-acetyl-
Catalog No.:AG0003I8 MDL No.:MFCD00065961
MF:C8H11N3O3 MW:197.1912
|
Silicic acid (H2SiO3), calcium salt (1:1)
Catalog No.:AG0003IX MDL No.:
MF: MW:
|
Sulfuric acid, calcium salt, hydrate (1:1:2)
Catalog No.:AG0003IW MDL No.:MFCD00149625
MF:CaH4O6S MW:172.1712
|
Sulfuric acid, chromium(3+) salt (3:2)
Catalog No.:AG0003IU MDL No.:MFCD00016039
MF: MW:
|
Cobalt tungsten oxide (CoWO4)
Catalog No.:AG0003IT MDL No.:
MF: MW:
|
Phosphoric acid, chromium(3+) salt (1:1), tetrahydrate (8CI,9CI)
Catalog No.:AG0003IS MDL No.:MFCD00150222
MF: MW:
|
Phosphoric acid, ammonium iron(2+) salt (1:1:1)
Catalog No.:AG0003IR MDL No.:
MF:FeH4NO4P MW:168.8548
|
Diphosphoric acid, ammonium manganese(3+) salt (1:1:1)
Catalog No.:AG0003IP MDL No.:
MF:H4MnNO7P2 MW:246.9198
|
Sulfuric acid, manganese(2+) salt, hydrate (1:1:4)
Catalog No.:AG0003IO MDL No.:MFCD00149160
MF: MW:
|
Dithionic acid, sodium salt, hydrate (1:2:2)
Catalog No.:AG0003IN MDL No.:
MF:H4Na2O8S2 MW:242.1365
|
Phosphorothioic acid, sodium salt (1:3)
Catalog No.:AG0003IM MDL No.:MFCD00150622
MF:Na3O3PS MW:180.0063
|
Phosphoric acid, sodium salt, hydrate (1:3:12)
Catalog No.:AG0003IL MDL No.:MFCD00149198
MF:H24Na3O16P MW:380.1240
|
Selenious acid, nickel(2+) salt (1:1)
Catalog No.:AG0003IJ MDL No.:
MF:NiO3Se MW:185.6516
|
Sulfuric acid, nickel(2+) salt, hydrate (1:1:6)
Catalog No.:AG0003II MDL No.:MFCD00149813
MF:H12NiO10S MW:262.8477
|
Sulfuric acid, nickel(2+) salt, hydrate (1:1:7)
Catalog No.:AG0003IH MDL No.:MFCD00149814
MF:H14NiO11S MW:280.8630
|
Guanidine, N-cyclohexyl-N'-phenyl-
Catalog No.:AG0003IG MDL No.:
MF:C13H19N3 MW:217.3101
|
Acetaldehyde, 2,2-bis(methylthio)-
Catalog No.:AG0003IF MDL No.:
MF:C4H8OS2 MW:136.2357
|
Ethanethioic acid, 2,2-bis(methylthio)-, S-methyl ester
Catalog No.:AG0003IE MDL No.:
MF:C5H10OS3 MW:182.3273
|
2-(1,3-thiazol-2-yl)acetonitrile
Catalog No.:AG0003ID MDL No.:MFCD06742776
MF:C5H4N2S MW:124.1637
|
Pyridine, 2-chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
Catalog No.:AG0003IB MDL No.:MFCD08063112
MF:C12H17BClNO2 MW:253.5329
|
Pyridine, 2-chloro-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
Catalog No.:AG0003IA MDL No.:MFCD08063084
MF:C12H17BClNO2 MW:253.5329
|
5'-Thymidylic acid, 3'-[5-[diethyl[2-(triethylammonio)ethyl]ammonio]pentanoate], bis(inner salt) (9CI)
Catalog No.:AG0003IC MDL No.:
MF: MW:
|
Boronic acid, B-(2,6-difluoro-4-propylphenyl)-
Catalog No.:AG0003J4 MDL No.:MFCD21337851
MF:C9H11BF2O2 MW:199.9902
|
1-Piperidinecarboxylic acid, 4-[[(5-bromo-2-pyridinyl)oxy]methyl]-, 1,1-dimethylethyl ester
Catalog No.:AG0003J3 MDL No.:MFCD11877792
MF:C16H23BrN2O3 MW:371.2694
|
1-Piperidinecarboxylic acid, 3-methyl-4-oxo-, phenylmethyl ester
Catalog No.:AG0003J2 MDL No.:MFCD11848402
MF:C14H17NO3 MW:247.2897
|
2,4(1H,3H)-Pyrimidinedione, 6-butyldihydro-
Catalog No.:AG0003JM MDL No.:
MF:C8H14N2O2 MW:170.2090
|
4-Pyrimidinamine, 5-bromo-2,6-dichloro-
Catalog No.:AG0003JL MDL No.:
MF:C4H2BrCl2N3 MW:242.8888
|
5-Thiazolecarboxylic acid, 2-chloro-
Catalog No.:AG0003JK MDL No.:MFCD02187331
MF:C4H2ClNO2S MW:163.5822
|
2-Thiazolecarboxylic acid, 5-chloro-
Catalog No.:AG0003JJ MDL No.:MFCD10000587
MF:C4H2ClNO2S MW:163.5822
|
3-Pyridineacetonitrile, 2-chloro-
Catalog No.:AG0003JI MDL No.:MFCD09923767
MF:C7H5ClN2 MW:152.5810
|
2-Thiazolamine, 5-methyl-4-(1-methylethyl)-
Catalog No.:AG0003JH MDL No.:MFCD12784032
MF:C7H12N2S MW:156.2486
|
2(3H)-Benzofuranone, 3-(1-hydroxyethylidene)-
Catalog No.:AG0003JG MDL No.:
MF:C10H8O3 MW:176.1687
|
Piperidine, 1-(3,3,5-trimethyl-1-cyclohexen-1-yl)-4-[3-[1-(3,5,5-trimethyl-1-cyclohexen-1-yl)-4-piperidinyl]propyl]- (9CI)
Catalog No.:AG0003JF MDL No.:
MF:C31H54N2 MW:454.7739
|
Phenol, 2,2'-dithiobis[5-(1,1-dimethylethyl)- (9CI)
Catalog No.:AG0003JE MDL No.:
MF:C20H26O2S2 MW:362.5492
|
1,2-Benzenedicarboxylic acid, bis(2-oxo-2-phenylethyl) ester (9CI)
Catalog No.:AG0003JD MDL No.:
MF:C24H18O6 MW:402.3961
|
2,5-Furandione, 3-(1-ethenylhexyl)dihydro-
Catalog No.:AG0003JC MDL No.:
MF:C12H18O3 MW:210.2695
|
Phosphoric acid, mono(2-methylpropyl) ester, diammonium salt (9CI)
Catalog No.:AG0003JB MDL No.:
MF:C4H17N2O4P MW:188.1625
|
Tridecanamine, N-tridecyl-, branched and linear
Catalog No.:AG0003JA MDL No.:
MF:C26H55N MW:381.7216
|
[1,2,4]Triazolo[1,5-a]pyridin-2-amine, 5-bromo-
Catalog No.:AG0003J1 MDL No.:MFCD11655928
MF:C6H5BrN4 MW:213.0347
|
2(1H)-Quinolinone, 3-(1H-indol-2-yl)-4-(4-methoxyphenyl)-1-methyl-
Catalog No.:AG0003J0 MDL No.:
MF:C25H20N2O2 MW:380.4385
|
Benzenebutanoic acid, γ-amino-, hydrochloride (1:1), (γR)-
Catalog No.:AG0003IZ MDL No.:MFCD12759018
MF:C10H14ClNO2 MW:215.6767
|
Piperazine, 1-(3-pyridinyl)-, hydrochloride (1:1)
Catalog No.:AG0003IY MDL No.:MFCD21396210
MF:C9H14ClN3 MW:199.6806
|
2,6-Dioxa-3,5-disilaheptane, 3,3,5,5-tetramethyl-4,4-bis(trimethylsilyl)-
Catalog No.:AG0003J9 MDL No.:
MF:C13H36O2Si4 MW:336.7657
|
Silane, [bis(fluorodimethylsilyl)methylene]bis[trimethyl- (9CI)
Catalog No.:AG0003J8 MDL No.:
MF:C11H30F2Si4 MW:312.6947
|
Silane, [bis(bromodimethylsilyl)methylene]bis[trimethyl- (9CI)
Catalog No.:AG0003J7 MDL No.:
MF:C11H30Br2Si4 MW:434.5059
|
Silane, [chloro(dimethylsilyl)methylene]bis[trimethyl- (9CI)
Catalog No.:AG0003J6 MDL No.:
MF:C9H25ClSi3 MW:253.0043
|
Silane, [chloro(methoxydimethylsilyl)methylene]bis[trimethyl- (9CI)
Catalog No.:AG0003J5 MDL No.:
MF:C10H27ClOSi3 MW:283.0303
|
Poly(oxy-1,3-propanediyloxy-1,4-phenylenecarbonyloxycarbonyl-1,4-phenylene)
Catalog No.:AG0003JU MDL No.:
MF:C17H14O5 MW:298.2901
|
1H-Benzimidazol-6-ol, 7-[(dimethylamino)methyl]-2-methyl-
Catalog No.:AG0003JT MDL No.:MFCD01089838
MF:C11H15N3O MW:205.2563
|
[1]Benzothiopyrano[3,4-d]imidazol-4(1H)-one, 1-butyl-2-(1-piperidinylmethyl)-
Catalog No.:AG0003JS MDL No.:
MF:C20H25N3OS MW:355.4970
|
Methanone, (2,3-dihydro-1,4-benzodioxin-6-yl)(4-fluorophenyl)-
Catalog No.:AG0003JR MDL No.:
MF:C15H11FO3 MW:258.2444
|
Methanone, (4-chlorophenyl)(2,3-dihydro-1,4-benzodioxin-6-yl)-
Catalog No.:AG0003JQ MDL No.:
MF:C15H11ClO3 MW:274.6990
|
Methanone, (4-bromophenyl)(2,3-dihydro-1,4-benzodioxin-6-yl)-
Catalog No.:AG0003JP MDL No.:
MF:C15H11BrO3 MW:319.1500
|
Ethanone, 1-(3,4-dihydro-2H-1-benzopyran-6-yl)-2-phenyl-
Catalog No.:AG0003JO MDL No.:
MF:C17H16O2 MW:252.3077
|
1-Propanone, 1-(3,4-dihydro-2H-1-benzopyran-6-yl)-3-phenyl-
Catalog No.:AG0003JN MDL No.:
MF:C18H18O2 MW:266.3343
|
Nitrous acid, zinc salt (8CI,9CI)
Catalog No.:AG0003KA MDL No.:
MF:N2O4Zn MW:157.3910
|
Nitrogen oxide (N2O5)
Catalog No.:AG0003K9 MDL No.:
MF: MW:
|
Nitric acid, palladium(2+) salt (2:1)
Catalog No.:AG0003K8 MDL No.:MFCD00011169
MF: MW:
|
Sulfurous acid, disodium salt, heptahydrate (9CI)
Catalog No.:AG0003K7 MDL No.:MFCD00149188
MF:H14Na2O10S MW:252.1497
|
Thiosulfuric acid (H2S2O3), sodium salt, hydrate (1:2:5)
Catalog No.:AG0003K6 MDL No.:MFCD00149186
MF:H10Na2O8S2 MW:248.1841
|
Selenic acid, disodium salt, decahydrate (9CI)
Catalog No.:AG0003K3 MDL No.:
MF:H20Na2O14Se MW:369.0899
|
Silicic acid (H2SiO3), lithium salt (1:2)
Catalog No.:AG0003K2 MDL No.:MFCD00016179
MF: MW:
|
Sulfuric acid, lithium salt, hydrate (1:2:1)
Catalog No.:AG0003K1 MDL No.:MFCD00149766
MF:H2Li2O5S MW:127.9599
|
Molybdate (MoO42-), sodium, hydrate (1:2:2), (T-4)- (9CI)
Catalog No.:AG0003K0 MDL No.:MFCD00149170
MF:H4MoNa2O6 MW:241.9677
|
Calcium iodide (CaI2)
Catalog No.:AG0003JW MDL No.:MFCD00010910
MF: MW:
|
Sulfuric acid, aluminum sodium salt (2:1:1)
Catalog No.:AG0003JV MDL No.:MFCD00040660
MF:AlNaO8S2 MW:242.0965
|
Bromic acid, calcium salt (8CI,9CI)
Catalog No.:AG0003KY MDL No.:MFCD00015970
MF:Br2CaO6 MW:295.8824
|
Diphosphoric acid, copper salt (1:?)
Catalog No.:AG0003KX MDL No.:MFCD00016061
MF: MW:
|
1H-Indole-3-carboxaldehyde, 5-bromo-1-methyl-
Catalog No.:AG0003KW MDL No.:MFCD03906373
MF:C10H8BrNO MW:238.0806
|
Glycine, N-[N-[1-[1-[1-(N-L-arginyl-L-threonyl)-L-prolyl]-L-prolyl]-L-prolyl]-L-seryl]- (9CI)
Catalog No.:AG0003KV MDL No.:
MF:C30H50N10O10 MW:710.7790
|
1H-Inden-2-ol, 2,3-dihydro-1-(methylthio)-
Catalog No.:AG0003KU MDL No.:
MF:C10H12OS MW:180.2667
|
2,2'-Bipyridinium, 1-dodecyl-, bromide (1:1)
Catalog No.:AG0003KT MDL No.:
MF:C22H34BrN2+ MW:406.4228
|
1,4-Butanediol, 2-chloro-, (2R)-
Catalog No.:AG0003KS MDL No.:
MF:C4H9ClO2 MW:124.5661
|
Quinoline, 8,8'-[3-oxetanylidenebis(methyleneoxy)]bis- (9CI)
Catalog No.:AG0003KR MDL No.:
MF:C23H20N2O3 MW:372.4165
|
Quinoline, 8,8'-[3-oxetanylidenebis(methyleneoxy)]bis[2-methyl- (9CI)
Catalog No.:AG0003KQ MDL No.:
MF:C25H24N2O3 MW:400.4697
|
Methanone, diphenyl-, O-[(3,4-dichlorophenoxy)acetyl]oxime (9CI)
Catalog No.:AG0003KP MDL No.:
MF:C21H15Cl2NO3 MW:400.2547
|
Phenol, 3-[(3,4-dihydro-2H-pyrrol-5-yl)amino]-2-methyl-, hydrochloride (1:1)
Catalog No.:AG0003KO MDL No.:
MF:C11H15ClN2O MW:226.7026
|
Silane, (3-chloro-1-iodopropyl)trimethyl-
Catalog No.:AG0003KN MDL No.:
MF:C6H14ClISi MW:276.6183
|
Silane, (1,3-diiodopropyl)trimethyl-
Catalog No.:AG0003KM MDL No.:
MF:C6H14I2Si MW:368.0698
|
Benzoic acid, 4-[chloro(hydroxyimino)methyl]-, methyl ester
Catalog No.:AG0003KL MDL No.:
MF:C9H8ClNO3 MW:213.6177
|
1H-Indole-2,3-dione, 6-(3-methyl-2-buten-1-yl)-
Catalog No.:AG0003KK MDL No.:
MF:C13H13NO2 MW:215.2478
|
3-Heptene, 4-(nitromethyl)-
Catalog No.:AG0003KJ MDL No.:
MF:C8H15NO2 MW:157.2102
|
Benzene, (11-bromoundecyl)-
Catalog No.:AG0003KI MDL No.:
MF:C17H27Br MW:311.3003
|
Cyclopentene, 3-ethenyl-2-ethyl-1-[(trimethylsilyl)oxy]-
Catalog No.:AG0003KH MDL No.:
MF:C12H22OSi MW:210.3880
|
3-Pyridinepropanoic acid, 5-(methoxycarbonyl)-β-oxo-, methyl ester
Catalog No.:AG0003KG MDL No.:
MF:C11H11NO5 MW:237.2087
|
2,2'-Bipyridine, 4,4'-bis(methylthio)-
Catalog No.:AG0003KF MDL No.:
MF:C12H12N2S2 MW:248.3671
|
[2,2'-Bipyridine]-4,4'(1H,1'H)-dithione
Catalog No.:AG0003KE MDL No.:
MF:C10H8N2S2 MW:220.3139
|
Silane, [(trimethylsilyl)methylidyne]tris[chlorodimethyl- (9CI)
Catalog No.:AG0003KD MDL No.:
MF:C10H27Cl3Si4 MW:366.0224
|
Thallium, compd. with thorium (1:1)
Catalog No.:AG0003KC MDL No.:
MF:ThTl MW:436.4214
|
Barium, compd. with zinc (1:2)
Catalog No.:AG0003LG MDL No.:
MF:BaZn2 MW:268.0870
|
Benzoic acid, 2-[[[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]amino]sulfonyl]-, methyl ester, mixt. with 2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulfonamide
Catalog No.:AG0003LF MDL No.:
MF:C26H27ClN10O10S2 MW:739.1366
|
Naphthalene, 2,3-dimethoxy-
Catalog No.:AG0003LN MDL No.:MFCD05664308
MF:C12H12O2 MW:188.2225
|
9-Octadecenoic acid (9Z)-, compd. with N,N-diethylethanamine (1:1)
Catalog No.:AG0003LM MDL No.:
MF: MW:
|
Thiosulfuric acid (H2S2O3), ammonium salt (1:1)
Catalog No.:AG0003LL MDL No.:
MF:H5NO3S2 MW:131.1746
|
Phosphoric acid, copper salt (1:?)
Catalog No.:AG0003LK MDL No.:
MF:CuO4P MW:158.5174
|
2-Butenamide, 3-chloro-N-[(4-hydroxy-3-methoxyphenyl)methyl]-
Catalog No.:AG0003LE MDL No.:
MF:C12H14ClNO3 MW:255.6975
|
Benzenesulfonyl fluoride, 3-[4,4,4-trifluoro-1-oxo-3-(trifluoromethyl)-2-buten-1-yl]-
Catalog No.:AG0003LD MDL No.:
MF:C11H5F7O3S MW:350.2094
|
Cyclobutaneacetic acid, α-hydroxy-α-1-propyn-1-yl-, 1-methyl-4-piperidinyl ester
Catalog No.:AG0003LC MDL No.:
MF:C15H23NO3 MW:265.3480
|
4,6-Heptadien-1-ol, methanesulfonate, (E)- (9CI)
Catalog No.:AG0003LB MDL No.:
MF:C8H14O3S MW:190.2600
|
1,3-Heptadiene, 7-bromo-, (3E)-
Catalog No.:AG0003LA MDL No.:
MF:C7H11Br MW:175.0662
|
Zinc, chloro(2,2-difluoroethenyl)-
Catalog No.:AG0003L9 MDL No.:
MF:C2HClF2Zn MW:163.8591
|
Benzoic acid, 4-(1,3-dithiolan-2-yl)-
Catalog No.:AG0003L8 MDL No.:MFCD06254774
MF:C10H10O2S2 MW:226.3152
|
2-Pentanone, 5-(1,3-dithian-2-yl)-
Catalog No.:AG0003L7 MDL No.:
MF:C9H16OS2 MW:204.3527
|
Zirconium, tetrakis[2-[bis(2-hydroxyethyl)amino-κN]ethanolato-κO]-
Catalog No.:AG0003L6 MDL No.:
MF: MW:
|
Zirconium, fluorohydroxyoxo- (9CI)
Catalog No.:AG0003L5 MDL No.:
MF:FHO2Zr MW:143.2291
|
Hydrazinecarboxamide, 2-(2-hydroxy-4-oxo-1(4H)-naphthalenylidene)-
Catalog No.:AG0003L4 MDL No.:
MF:C11H9N3O3 MW:231.2075
|
Benzoic acid, 4-(1-pyrrolidinyl)-, ethyl ester
Catalog No.:AG0003L3 MDL No.:
MF:C13H17NO2 MW:219.2796
|
Benzoic acid, 4-(1-piperidinyl)-, ethyl ester
Catalog No.:AG0003L2 MDL No.:MFCD09473342
MF:C14H19NO2 MW:233.3062
|
3H-IndoliuM, 2-[3-[1,3-dihydro-3,3-diMethyl-1-[6-oxo-6-(2-propyn-1-ylaMino)hexyl]-5-sulfo-2H-indol-2-ylidene]-1-propen-1-yl]-1-ethyl-3,3-diMethyl-5-sulfo-
Catalog No.:AG0003L0 MDL No.:
MF:C34H42N3O7S2+ MW:668.8432
|
3-Pyrrolidinecarbonitrile, 1-(phenylmethyl)-, hydrochloride (1:1), (3R)-
Catalog No.:AG0003KZ MDL No.:
MF: MW:
|
Uridine, 2'-deoxy-5-iodo-5'-O-(triphenylmethyl)-, 3'-methanesulfonate
Catalog No.:AG0003L1 MDL No.:
MF:C29H27IN2O7S MW:674.5034
|
Lithium, (4-butylphenyl)-
Catalog No.:AG0003LH MDL No.:
MF:C10H13Li MW:140.1512
|
Piperazine, 1-(8-chloro-10,11-dihydrodibenzo[b,f]thiepin-10-yl)-4-(3-methoxypropyl)-, (2Z)-2-butenedioate (1:2)
Catalog No.:AG0003MC MDL No.:
MF:C30H35ClN2O9S MW:635.1249
|
Piperazine, 1-(8-chloro-10,11-dihydrodibenzo[b,f]thiepin-10-yl)-4-(2-ethoxyethyl)-, (2Z)-2-butenedioate (1:1)
Catalog No.:AG0003MB MDL No.:
MF:C26H31ClN2O5S MW:519.0527
|
Piperazine, 1-(2-chloro-10,11-dihydrodibenzo[b,f]thiepin-10-yl)-4-(2-methoxyethyl)-, (2Z)-2-butenedioate (1:2)
Catalog No.:AG0003MA MDL No.:
MF:C29H33ClN2O9S MW:621.0983
|
Piperazine, 1-(2-chloro-10,11-dihydrodibenzo[b,f]thiepin-10-yl)-4-(2-phenoxyethyl)-, (2Z)-2-butenedioate (1:1)
Catalog No.:AG0003M9 MDL No.:
MF:C30H31ClN2O5S MW:567.0955
|
Urea, N-(3-chlorophenyl)-N'-(3-methyl-2-thiazolidinylidene)-
Catalog No.:AG0003M8 MDL No.:
MF:C11H12ClN3OS MW:269.7505
|
3-Pyridazinamine, N-cyclobutyl-
Catalog No.:AG0003LZ MDL No.:
MF:C8H11N3 MW:149.1930
|
1-Piperidinecarboxylic acid, 4-[[(2-methoxyphenyl)sulfonyl]amino]-, 1,1-dimethylethyl ester
Catalog No.:AG0003LY MDL No.:
MF:C17H26N2O5S MW:370.4637
|
Benzene, 1-bromo-3-fluoro-2-propoxy-
Catalog No.:AG0003LX MDL No.:
MF:C9H10BrFO MW:233.0775
|
2-Pyridinamine, 5-bromo-N-cyclopropyl-3-nitro-
Catalog No.:AG0003LW MDL No.:MFCD08692115
MF:C8H8BrN3O2 MW:258.0720
|
3-Pyridazinamine, 6-chloro-N-cyclobutyl-
Catalog No.:AG0003LV MDL No.:
MF:C8H10ClN3 MW:183.6381
|
Benzene, 1-bromo-3-fluoro-2-(2-propen-1-yloxy)-
Catalog No.:AG0003LU MDL No.:MFCD11036145
MF:C9H8BrFO MW:231.0616
|
Pyridine, 5-bromo-4-methyl-2-(trifluoromethyl)-
Catalog No.:AG0003LT MDL No.:MFCD18257679
MF:C7H5BrF3N MW:240.0205
|
Pyridine, 5-bromo-3-methyl-2-(trifluoromethyl)-
Catalog No.:AG0003LS MDL No.:MFCD18257678
MF:C7H5BrF3N MW:240.0205
|
Pyridine, 3-bromo-2-methyl-6-(trifluoromethyl)-
Catalog No.:AG0003LR MDL No.:MFCD18255964
MF:C7H5BrF3N MW:240.0205
|
1-Piperidinecarboxylic acid, 4-[(2,2-difluoroethyl)amino]-, 1,1-dimethylethyl ester
Catalog No.:AG0003LQ MDL No.:
MF:C12H22F2N2O2 MW:264.3121
|
2-Pyridinecarboxylic acid, 6-(trifluoromethyl)-, ethyl ester
Catalog No.:AG0003LP MDL No.:MFCD11036140
MF:C9H8F3NO2 MW:219.1605
|
Thiophene, 2-ethyl-, 1,1-dioxide
Catalog No.:AG0003M7 MDL No.:
MF:C6H8O2S MW:144.1915
|
[1,1'-Biphenyl]-2-ol, 4'-methyl-
Catalog No.:AG0003M6 MDL No.:MFCD06802423
MF:C13H12O MW:184.2338
|
Pyrene, 1-nitro-6-nitroso-
Catalog No.:AG0003M5 MDL No.:
MF:C16H8N2O3 MW:276.2463
|
Mercury, [4-(acetyloxy)phenyl]chloro-
Catalog No.:AG0003M4 MDL No.:
MF:C8H7ClHgO2 MW:371.1830
|
1-Pyrrolidinecarboxylic acid, 3-(1-piperazinyl)-, 1,1-dimethylethyl ester, (3S)-
Catalog No.:AG0003LO MDL No.:MFCD18633366
MF:C13H25N3O2 MW:255.3565
|
Ethanone, 2-[(4-amino-5-benzoyl-3-phenyl-2-thienyl)thio]-1-phenyl-
Catalog No.:AG0003M3 MDL No.:
MF:C25H19NO2S2 MW:429.5539
|
3-Pyridinecarbonitrile, 6-cyclopropyl-1,2-dihydro-2-thioxo-
Catalog No.:AG0003M2 MDL No.:
MF:C9H8N2S MW:176.2382
|
Benzaldehyde, 2-[(4-bromophenyl)methoxy]-
Catalog No.:AG0003M1 MDL No.:MFCD00595786
MF:C14H11BrO2 MW:291.1399
|
Benzonitrile, 4-[6-(dimethylamino)-2-benzofuranyl]-
Catalog No.:AG0003M0 MDL No.:
MF:C17H14N2O MW:262.3059
|
Benzonitrile, 4-[(1E)-4,4,4-trifluoro-3-oxo-1-buten-1-yl]-
Catalog No.:AG0003MV MDL No.:
MF:C11H6F3NO MW:225.1666
|
Benzonitrile, 3-[(1E)-4,4,4-trifluoro-3-oxo-1-buten-1-yl]-
Catalog No.:AG0003MU MDL No.:
MF:C11H6F3NO MW:225.1666
|
Benzonitrile, 2-fluoro-4-formyl-
Catalog No.:AG0003MT MDL No.:MFCD06738989
MF:C8H4FNO MW:149.1219
|
Benzonitrile, 2-chloro-4-formyl-
Catalog No.:AG0003MS MDL No.:MFCD18392411
MF:C8H4ClNO MW:165.5765
|
1-Decen-3-one, 2-fluoro-
Catalog No.:AG0003MR MDL No.:
MF:C10H17FO MW:172.2398
|
Hexanoic acid, 2-ethyl-2-(hydroxymethyl)-
Catalog No.:AG0003MQ MDL No.:
MF:C9H18O3 MW:174.2374
|
Benzene, tribromofluoro- (9CI)
Catalog No.:AG0003MP MDL No.:
MF:C6H2Br3F MW:332.7905
|
Bicyclo[2.2.1]heptane-2,3-diol, 1,7,7-trimethyl-, 2,3-diacetate
Catalog No.:AG0003MO MDL No.:
MF:C14H22O4 MW:254.3221
|
2-Butanol, 4,4,4-trifluoro-
Catalog No.:AG0003MN MDL No.:MFCD07784221
MF:C4H7F3O MW:128.0930
|
2-Butanol, 1,1,1-trifluoro-, (2R)-
Catalog No.:AG0003MM MDL No.:
MF:C4H7F3O MW:128.0930
|
4-Imidazolidinone, 1-benzoyl-2-(1,1-dimethylethyl)-3-methyl-, (2S)-
Catalog No.:AG0003ML MDL No.:
MF:C15H20N2O2 MW:260.3315
|
4-Imidazolidinone, 1-benzoyl-2-(1,1-dimethylethyl)-3-methyl-, (2R)-
Catalog No.:AG0003MK MDL No.:
MF:C15H20N2O2 MW:260.3315
|
1,3,5-Hexatrien-1-one, (3Z)-
Catalog No.:AG0003MJ MDL No.:
MF:C6H6O MW:94.1112
|
Phosphine, (2-methylpropylidyne)- (9CI)
Catalog No.:AG0003MI MDL No.:
MF:C4H9P MW:88.0880
|
Phosphine, (3,3-dimethylbutylidyne)-
Catalog No.:AG0003MH MDL No.:
MF:C6H13P MW:116.1412
|
Phosphine, (tricyclo[3.3.1.13,7]dec-1-ylmethylidyne)-
Catalog No.:AG0003MG MDL No.:
MF:C11H17P MW:180.2264
|
Phosphine, [(1-methylcyclohexyl)methylidyne]-
Catalog No.:AG0003MF MDL No.:
MF:C8H15P MW:142.1785
|
1,4-Methanopentalene-2-carbonyl chloride, octahydro-
Catalog No.:AG0003ME MDL No.:
MF:C10H13ClO MW:184.6626
|
1,4-Methanopentalene-3-carbonyl chloride, octahydro-
Catalog No.:AG0003MD MDL No.:
MF:C10H13ClO MW:184.6626
|